Impaired	0	8	O
coronary	9	17	B-Multi-tissue_structure
collateral	18	28	I-Multi-tissue_structure
vessel	29	35	I-Multi-tissue_structure
development	36	47	O
in	48	50	O
patients	51	59	B-Organism
with	60	64	O
proliferative	65	78	O
diabetic	79	87	O
retinopathy	88	99	O
.	99	100	O

BACKGROUND	102	112	O
:	112	113	O
Diabetic	114	122	O
patients	123	131	B-Organism
have	132	136	O
been	137	141	O
reported	142	150	O
to	151	153	O
have	154	158	O
impaired	159	167	O
coronary	168	176	B-Multi-tissue_structure
collateral	177	187	I-Multi-tissue_structure
vessel	188	194	I-Multi-tissue_structure
growth	195	201	O
,	201	202	O
although	203	211	O
they	212	216	O
have	217	221	O
excessive	222	231	O
neovascularization	232	250	O
in	251	253	O
the	254	257	O
retina	258	264	B-Multi-tissue_structure
.	264	265	O

HYPOTHESIS	266	276	O
:	276	277	O
This	278	282	O
study	283	288	O
was	289	292	O
designed	293	301	O
to	302	304	O
compare	305	312	O
coronary	313	321	O
collateral	322	332	O
circulation	333	344	O
(	345	346	O
CCC	346	349	O
)	349	350	O
in	351	353	O
patients	354	362	B-Organism
with	363	367	O
proliferative	368	381	O
diabetic	382	390	O
retinopathy	391	402	O
(	403	404	O
PDR	404	407	O
)	407	408	O
with	409	413	O
that	414	418	O
in	419	421	O
patients	422	430	B-Organism
without	431	438	O
DR	439	441	O
.	441	442	O

METHODS	443	450	O
:	450	451	O
Ninety	452	458	O
diabetic	459	467	O
patients	468	476	B-Organism
with	477	481	O
chronic	482	489	O
total	490	495	O
occlusion	496	505	O
in	506	508	O
at	509	511	O
least	512	517	O
one	518	521	O
major	522	527	O
epicardial	528	538	B-Multi-tissue_structure
coronary	539	547	I-Multi-tissue_structure
artery	548	554	I-Multi-tissue_structure
were	555	559	O
enrolled	560	568	O
in	569	571	O
the	572	575	O
study	576	581	O
.	581	582	O

Groups	583	589	O
1	590	591	O
and	592	595	O
2	596	597	O
consisted	598	607	O
of	608	610	O
48	611	613	O
patients	614	622	B-Organism
without	623	630	O
DR	631	633	O
and	634	637	O
42	638	640	O
patients	641	649	B-Organism
with	650	654	O
PDR	655	658	O
,	658	659	O
respectively	660	672	O
.	672	673	O

Coronary	674	682	O
collateral	683	693	O
circulation	694	705	O
(	706	707	O
CCC	707	710	O
)	710	711	O
was	712	715	O
analyzed	716	724	O
according	725	734	O
to	735	737	O
the	738	741	O
Rentrop	742	749	O
system	750	756	O
.	756	757	O

Each	758	762	O
group	763	768	O
was	769	772	O
also	773	777	O
divided	778	785	O
into	786	790	O
two	791	794	O
subgroups	795	804	O
according	805	814	O
to	815	817	O
poor	818	822	O
and	823	826	O
good	827	831	O
CCC	832	835	O
.	835	836	O

Serum	837	842	B-Organism_substance
vascular	843	851	B-Gene_or_gene_product
endothelial	852	863	I-Gene_or_gene_product
growth	864	870	I-Gene_or_gene_product
factor	871	877	I-Gene_or_gene_product
(	878	879	O
VEGF	879	883	B-Gene_or_gene_product
)	883	884	O
levels	885	891	O
were	892	896	O
measured	897	905	O
using	906	911	O
the	912	915	O
enzyme	916	922	O
-	922	923	O
linked	923	929	O
immunosorbent	930	943	O
assay	944	949	O
(	950	951	O
ELISA	951	956	O
)	956	957	O
kit	958	961	O
.	961	962	O

RESULTS	963	970	O
:	970	971	O
The	972	975	O
mean	976	980	O
Rentrop	981	988	O
collateral	989	999	O
score	1000	1005	O
was	1006	1009	O
higher	1010	1016	O
in	1017	1019	O
Group	1020	1025	O
1	1026	1027	O
than	1028	1032	O
in	1033	1035	O
Group	1036	1041	O
2	1042	1043	O
(	1044	1045	O
2	1045	1046	O
.	1046	1047	O
39	1047	1049	O
+	1050	1051	O
/	1051	1052	O
-	1052	1053	O
1	1054	1055	O
.	1055	1056	O
07	1056	1058	O
vs	1059	1061	O
.	1061	1062	O
1	1063	1064	O
.	1064	1065	O
76	1065	1067	O
+	1068	1069	O
/	1069	1070	O
-	1070	1071	O
0	1072	1073	O
.	1073	1074	O
76	1074	1076	O
,	1076	1077	O
respectively	1078	1090	O
,	1090	1091	O
p	1092	1093	O
less	1095	1099	O
than	1100	1104	O
0	1106	1107	O
.	1107	1108	O
001	1108	1111	O
)	1111	1112	O
.	1112	1113	O

When	1114	1118	O
the	1119	1122	O
two	1123	1126	O
groups	1127	1133	O
were	1134	1138	O
compared	1139	1147	O
with	1148	1152	O
respect	1153	1160	O
to	1161	1163	O
poor	1164	1168	O
and	1169	1172	O
good	1173	1177	O
CCC	1178	1181	O
,	1181	1182	O
poor	1183	1187	O
CCC	1188	1191	O
was	1192	1195	O
higher	1196	1202	O
in	1203	1205	O
patients	1206	1214	B-Organism
with	1215	1219	O
PDR	1220	1223	O
(	1224	1225	O
64	1225	1227	O
vs	1228	1230	O
.	1230	1231	O
36	1232	1234	O
%	1234	1235	O
,	1235	1236	O
respectively	1237	1249	O
,	1249	1250	O
p	1251	1252	O
=	1253	1254	O
0	1255	1256	O
.	1256	1257	O
01	1257	1259	O
)	1259	1260	O
.	1260	1261	O

Serum	1262	1267	B-Organism_substance
VEGF	1268	1272	B-Gene_or_gene_product
levels	1273	1279	O
were	1280	1284	O
higher	1285	1291	O
in	1292	1294	O
patients	1295	1303	B-Organism
with	1304	1308	O
PDR	1309	1312	O
than	1313	1317	O
in	1318	1320	O
those	1321	1326	O
without	1327	1334	O
DR	1335	1337	O
(	1338	1339	O
219	1339	1342	O
+	1343	1344	O
/	1344	1345	O
-	1345	1346	O
99	1347	1349	O
vs	1350	1352	O
.	1352	1353	O
139	1354	1357	O
+	1358	1359	O
/	1359	1360	O
-	1360	1361	O
98	1362	1364	O
pg	1365	1367	O
/	1367	1368	O
ml	1368	1370	O
,	1370	1371	O
p	1372	1373	O
less	1375	1379	O
than	1380	1384	O
0	1386	1387	O
.	1387	1388	O
001	1388	1391	O
)	1391	1392	O
;	1392	1393	O
however	1394	1401	O
,	1401	1402	O
patients	1403	1411	B-Organism
with	1412	1416	O
poor	1417	1421	O
and	1422	1425	O
good	1426	1430	O
CCC	1431	1434	O
had	1435	1438	O
similar	1439	1446	O
VEGF	1447	1451	B-Gene_or_gene_product
levels	1452	1458	O
.	1458	1459	O

CONCLUSIONS	1460	1471	O
:	1471	1472	O
We	1473	1475	O
have	1476	1480	O
shown	1481	1486	O
that	1487	1491	O
patients	1492	1500	B-Organism
with	1501	1505	O
PDR	1506	1509	O
have	1510	1514	O
a	1515	1516	O
lower	1517	1522	O
coronary	1523	1531	O
collateral	1532	1542	O
score	1543	1548	O
than	1549	1553	O
patients	1554	1562	B-Organism
without	1563	1570	O
DR	1571	1573	O
.	1573	1574	O

Also	1575	1579	O
,	1579	1580	O
serum	1581	1586	B-Organism_substance
VEGF	1587	1591	B-Gene_or_gene_product
was	1592	1595	O
significantly	1596	1609	O
higher	1610	1616	O
in	1617	1619	O
patients	1620	1628	B-Organism
with	1629	1633	O
PDR	1634	1637	O
than	1638	1642	O
in	1643	1645	O
those	1646	1651	O
without	1652	1659	O
DR	1660	1662	O
.	1662	1663	O

These	1664	1669	O
findings	1670	1678	O
have	1679	1683	O
suggested	1684	1693	O
that	1694	1698	O
diabetes	1699	1707	O
mellitus	1708	1716	O
may	1717	1720	O
have	1721	1725	O
a	1726	1727	O
different	1728	1737	O
action	1738	1744	O
on	1745	1747	O
retinal	1748	1755	B-Multi-tissue_structure
and	1756	1759	O
coronary	1760	1768	B-Multi-tissue_structure
circulation	1769	1780	O
.	1780	1781	O

